1. MARKETS
  2. SECTOR : DIVERSIFIED CONSUMER SERVICES
  3. INDUSTRY : HEALTHCARE SERVICES
  4. BRIGHTSPRING HEALTH SERVICES INC

BrightSpring Health Services Inc

XNAS: BTSG

Expensive Performer
Download real time

18.13 -0.21 (-1.15%)

26.95% Fall from 52W High

1.4M XNAS Volume

XNAS 20 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
13S
4W
5O
0T
3,172.3

Market Cap

High in industry
-175.6

PE TTM

Negative PE TTM
-2

PEG TTM

PEG TTM is negative
2

Price to Book

Below industry Median
0.2

Beta 1Year

Very Low volatility


Insider Trading disclosures for BrightSpring Health Services Inc

The latest disclosure was made by Jennifer Phipps in BrightSpring Health Services Inc where a trade of 183,374 Stock Options (Right to Buy) done was reported to US exchanges on March 17, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jennifer Phipps Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2025 183,374 183,374 - - Stock Options (Right to Buy)
Jennifer Phipps Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2025 86,356 230,030 - 0 Common Stock
Lisa Nalley See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2025 97,800 97,800 - - Stock Options (Right to Buy)
Lisa Nalley See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2025 46,057 131,150 - 0 Common Stock
Jennifer Yowler President, PharMerica Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2025 48,900 48,900 - - Stock Options (Right to Buy)
Jennifer Yowler President, PharMerica Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2025 23,029 75,401 - 0 Common Stock
Jon B. Rousseau Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2025 345,424 1,233,020 - 0 Common Stock
Jon B. Rousseau Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2025 733,496 733,496 - - Stock Options (Right to Buy)
Bob Barnes President, Community Living Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. 25 Jan 2025 7,351 42,393 - 22.8 167,750 Common Stock
Jon B. Rousseau Director, See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. 25 Jan 2025 44,362 887,596 - 22.8 1,012,341 Common Stock
Jim Mattingly See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. 25 Jan 2025 12,115 122,665 - 22.8 276,464 Common Stock
Jennifer Yowler President, PharMerica Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. 25 Jan 2025 8,508 52,372 - 22.8 194,153 Common Stock
Mike McMaude See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. 25 Jan 2025 7,202 326,888 - 22.8 164,350 Common Stock
Lisa Nalley See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. 25 Jan 2025 14,501 85,093 - 22.8 330,913 Common Stock
Jennifer Phipps Chief Accounting Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.82 per share. 25 Jan 2025 21,944 143,674 - 22.8 500,762 Common Stock
Steven B. Miller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Nov 2024 10,708 10,708 - 0 Common Stock
Jon B. Rousseau Director, See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.50 per share. 25 Oct 2024 36,740 931,958 - 15.5 569,470 Common Stock
Jon B. Rousseau Director, See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.09 per share. 25 Jul 2024 20,198 968,698 - 12.1 244,194 Common Stock
Matthew D’Ambrosio Director Purchase of securities on an exchange or from another person at price $ 11.46 per share. 20 May 2024 1,000 1,000 - 11.5 11,461 Common Stock
Olivia F. Kirtley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2024 4,449 20,102 - 0 Common Stock
Timothy A. Wicks Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2024 15,653 15,653 - 0 Common Stock
Olivia F. Kirtley Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 May 2024 15,653 15,653 - 0 Common Stock
Jon B. Rousseau Director, See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.41 per share. 25 Apr 2024 36,740 988,896 - 10.4 382,463 Common Stock
Jon B. Rousseau Director, See Remarks Purchase of securities on an exchange or from another person at price $ 8.09 per share. 15 Mar 2024 18,400 1,025,636 - 8.1 148,856 Common Stock
Jon B. Rousseau Director, See Remarks Purchase of securities on an exchange or from another person at price $ 8.09 per share. 15 Mar 2024 18,400 369,763 - 8.1 148,856 Common Stock
Jim Mattingly See Remarks Purchase of securities on an exchange or from another person at price $ 8.26 per share. 15 Mar 2024 6,080 134,780 - 8.3 50,221 Common Stock
Jennifer Yowler President, PharMerica Purchase of securities on an exchange or from another person at price $ 8.21 per share. 15 Mar 2024 3,000 60,880 - 8.2 24,630 Common Stock
Jon B. Rousseau Director, See Remarks Purchase of securities on an exchange or from another person at price $ 8.12 per share. 14 Mar 2024 37,405 1,007,236 - 8.1 303,729 Common Stock
Jim Mattingly See Remarks Purchase of securities on an exchange or from another person at price $ 8.18 per share. 14 Mar 2024 12,280 128,700 - 8.2 100,450 Common Stock
Jennifer Phipps Chief Accounting Officer Purchase of securities on an exchange or from another person at price $ 8.14 per share. 14 Mar 2024 12,300 165,618 - 8.1 100,122 Common Stock
Jennifer Yowler President, PharMerica Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 57,880 57,880 - 0 Common Stock
Steven S. Reed See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 19,837 19,837 - - Stock Options (Right to Buy)
Steven S. Reed See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 54,658 93,914 - 0 Common Stock
Steven S. Reed See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 60,847 182,543 - - Stock Options (Right to Buy)
Jim Mattingly See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 184,506 553,520 - - Stock Options (Right to Buy)
Jim Mattingly See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 77,164 116,420 - 0 Common Stock
Jim Mattingly See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 28,005 28,005 - - Stock Options (Right to Buy)
Jennifer Yowler President, PharMerica Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 17,665 52,996 - - Stock Options (Right to Buy)
Jennifer Yowler President, PharMerica Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 17,665 52,996 - - Stock Options (Right to Buy)
Jennifer Yowler President, PharMerica Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 21,004 21,004 - - Stock Options (Right to Buy)
Lisa Nalley See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 96,454 99,594 - 0 Common Stock
Bob Barnes President, Community Living Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 2,944 8,832 - - Stock Options (Right to Buy)
Bob Barnes President, Community Living Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 46,620 49,744 - 0 Common Stock
Bob Barnes President, Community Living Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 35,331 105,993 - - Stock Options (Right to Buy)
Bob Barnes President, Community Living Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 16,919 16,919 - - Stock Options (Right to Buy)
Mike McMaude See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 18,670 18,670 - - Stock Options (Right to Buy)
Mike McMaude See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 51,442 334,090 - 0 Common Stock
Mike McMaude See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 33,349 103,048 - - Stock Options (Right to Buy)
Jennifer Phipps Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 52,509 52,509 - - Stock Options (Right to Buy)
Jennifer Phipps Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 144,682 153,318 - 0 Common Stock
Jennifer Phipps Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 35,331 105,993 - - Stock Options (Right to Buy)
Jennifer Phipps Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 5,888 17,655 - - Stock Options (Right to Buy)
Lisa Nalley See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 35,331 105,993 - - Stock Options (Right to Buy)
Lisa Nalley See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 35,006 35,006 - - Stock Options (Right to Buy)
Lisa Nalley See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2024 3,925 11,777 - - Stock Options (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters